FibroBiologics, Inc. (FBLG)

FibroBiologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021
Market Capitalization	135	-	-	-
Enterprise Value	129	-7	5	1
PB Ratio	-91.32	-	-	-
EV/EBITDA Ratio	-	0.46	-1.20	-0.71
EV/EBIT Ratio	-	0.45	-1.18	-0.71
EV/FCF Ratio	-	1.05	-1.29	-0.79
Debt / Equity Ratio	-0.55	1.51	-1.88	-1.18
Debt / EBITDA Ratio	-	-0.12	-1.72	-0.97
Debt / FCF Ratio	-	-0.27	-1.85	-1.08
Quick Ratio	0.58	1.00	0.32	0.23
Current Ratio	0.64	1.00	0.37	0.27
Interest Coverage	-	-111.14	-6.83	-394.50
Return on Equity (ROE)	-	1389.60%	193.80%	-
Return on Assets (ROA)	-	-229.00%	-193.50%	-
Return on Capital (ROIC)	-	-283.00%	-126.62%	-671.49%
Earnings Yield	-16.63%	-	-	-
Buyback Yield / Dilution	-10.28%	-	-	-
Total Shareholder Return	-10.28%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).